Novel and de novo point and large microdeletion mutation in PRRT2-related epilepsy

Li Yang1,2, Cuiping You3, Shiyan Qiu2

  • 1Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China.

Brain and Behavior
|April 3, 2020
PubMed

Insights

Point mutations and copy number variants in the PRRT2 gene are linked to childhood epilepsy. This study identified PRRT2 mutations in Chinese children, expanding the known spectrum of related epilepsy syndromes and genetic variations.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Point and copy number variant mutations in the *PRRT2* gene are associated with paroxysmal disorders and epilepsy.
  • Understanding the spectrum of *PRRT2*-related mutations and their clinical manifestations in diverse populations is crucial.

Purpose of the Study:

  • To analyze the phenotypes and *PRRT2*-related mutations in Chinese children diagnosed with epilepsy.
  • To expand the understanding of *PRRT2* mutation spectrum and associated epilepsy types.

Main Methods:

  • Whole exome sequencing (WES) and low-coverage massively parallel CNV sequencing (CNV-seq) were performed on 492 children with epilepsy.
  • Quantitative polymerase chain reaction (qPCR) was used to verify copy number variations (CNVs).
  • Clinical information and follow-up data were collected for all analyzed patients.

Main Results:

  • *PRRT2*-related mutations were identified in 19 pediatric epilepsy patients (10 males, 9 females).
  • Detected mutations included 12 point mutations, 4 whole gene deletions, and 3 deletions in the 16p11.2 region.
  • Clinical phenotypes encompassed early childhood myoclonic epilepsy (ECME), febrile seizures (FS), infantile convulsions with paroxysmal choreoathetosis (ICCA), paroxysmal kinesigenic dyskinesias (PKD), benign infantile epilepsy (BIE), and benign familial infantile epilepsy (BFIE).
  • Most patients responded well to valproic acid (VPA) or oxcarbazepine (OXC).

Conclusions:

  • *PRRT2* mutations, primarily inherited, contribute to a spectrum of epilepsy syndromes including BIE, BFIE, ICCA, PKD, FS, and ECME.
  • The study reports the first instance of *PRRT2* mutation associated with ECME.
  • *PRRT2*-related mutations encompass point mutations, whole gene deletions, and large microdeletions, broadening the known genetic and clinical landscape of *PRRT2*-associated epilepsy.
Abstract